March 03, 2023
A Closing Thought
32
3
The responsibility of increasing diversity falls on every stakeholder in the clinical trial value chain.
March 03, 2023
Feature Articles
32
3
Survey examines trial enrollment motivation among diverse populations.
March 03, 2023
Feature Articles
32
3
Advancing responsible AI innovation to help resolve patient disparities.
March 02, 2023
Feature Articles
32
3
Outlining new approaches and resources to help ignite progress in this area.
March 02, 2023
Clinical Trial Insights
32
3
Self-determined eligibility and the influence of clinical care challenge this flawed figure.
March 02, 2023
Data Collection
32
3
EU Medical Device Regulation must be followed carefully as it leaves room for interpretation.
March 02, 2023
RBQM
32
3
Industry sees high increase in the use of QTLs.
March 02, 2023
News
32
3
Panel discussion at SCOPE highlights strategies to increase diversity in clinical trials.
March 02, 2023
View from Brussels
32
3
Reformed EMA looks to tackle challenges in drug development, pediatric medicines, and unmet medical need.
March 02, 2023
From the Editor
32
3
Noise in modern day life may be interfering with our ability to learn.
March 02, 2023
Issue PDF
32
3
Click the title above for a link to open the Applied Clinical Trials March 2023 issue in an interactive PDF format.
February 14, 2023
Q&A
32
3
Sanjay Shukla, MD, MS, CEO of aTyr Pharma, discusses the company's clinical operations and ongoing Phase III study for pulmonary sarcoidosis.
February 13, 2023
View from Washington
32
3
With industry’s uneven track record in patient representation, sponsors now mandated to submit Diversity Action Plans (DAPs) to FDA for Phase III and pivotal studies.
February 06, 2023
Feature Articles
32
3
Researchers face various challenges that cause their clinical trials to fail to meet enrollment timelines, among other issues.